Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Immune Evasion by CMV and BK Virus: Lurking Viruses Waiting for the Right Moment to Deliver a Fatal Blow to Individuals With Compromised Immunity.

Created on 23 Oct 2026

Authors

Luobin Robin Zheng, Maike Zheng, Yongqiang Wang, Shijun J Zheng

Published in

Journal of immunology research. Volume 2026. Issue 1. Pages e2341054.

Abstract

Human cytomegalovirus (CMV) and BK polyomavirus are archetypal latent DNA viruses that establish lifelong persistence and cause severe disease upon reactivation in immunocompromised hosts. Although they differ markedly in virion architecture, genome size, and coding capacity, both viruses converge on a shared biological principle: durable persistence is achieved through sustained immune invisibility rather than maximal replication. CMV is a large, enveloped double-stranded DNA (dsDNA) virus whose multilayered structure supports the expression of numerous immunomodulatory proteins that disrupt antigen processing and presentation, modulate natural killer cell surveillance, and reshape cytokine and chemokine networks. In contrast, BK virus (BKV) is a small, nonenveloped dsDNA virus that achieves immune evasion through functional minimalism, restricting viral gene expression, limiting antigen availability, and attenuating innate immune sensing pathways. These distinct yet convergent immune evasion strategies complicate diagnosis, constrain the efficacy of antiviral therapies, and promote viral persistence in vulnerable patients. By integrating structural and biological features with mechanisms of immune escape, this review primarily focuses on how immune modulation blurs the classical distinction between latency and active infection, highlighting implications for clinical monitoring, therapy, and emerging immune-guided strategies for the effective control of viral infection in immunocompromised individuals.

PMID:
42904809
Bibliographic data and abstract were imported from PubMed on 23 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement